Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$629M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$394M |
| 4 |
NVIDIA
NVDA
|
+$306M |
| 5 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$964M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$620M |
| 3 |
Invesco Senior Loan ETF
BKLN
|
+$369M |
| 4 |
Tencent Music
TME
|
+$338M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.5% |
| 2 | Technology | 2.1% |
| 3 | Healthcare | 1.18% |
| 4 | Financials | 0.9% |
| 5 | Industrials | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7001
Credicorp
BAP
$30.7B
| $562K | ﹤0.01% |
4,640
-1,995
| -30% | -$261K |
|
|
CSPR
7002
CALL
DELISTED
Casper Sleep Inc.
CSPR
| $562K | ﹤0.01% |
+68,200
| New | +$595K |
|
|
CXP
7003
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $562K | ﹤0.01% |
32,325
-85,481
| -73% | -$1.54M |
|
7004
PUT
Axalta
AXTA
$8.05B
| $561K | ﹤0.01% |
18,400
-18,700
| -50% | -$592K |
|
7005
PUT
Dana Inc
DAN
$3.28B
| $561K | ﹤0.01% |
23,600
-27,800
| -54% | -$721K |
|
|
DCP
7006
DELISTED
DCP Midstream, LP
DCP
| $561K | ﹤0.01% |
18,283
-26,551
| -59% | -$686K |
|
7007
Schrodinger
SDGR
$1.4B
| $560K | ﹤0.01% |
7,411
-23,324
| -76% | -$1.69M |
|
|
COWN
7008
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $560K | ﹤0.01% |
13,635
-8,514
| -38% | -$334K |
|
7009
Aecom
ACM
$8.5B
| $559K | ﹤0.01% |
8,830
+2,459
| +39% | +$161K |
|
7010
CALL
Alarm.com
ALRM
$2.74B
| $559K | ﹤0.01% |
6,600
-8,800
| -57% | -$752K |
|
7011
CALL
Maravai LifeSciences
MRVI
$907M
| $559K | ﹤0.01% |
+13,400
| New | +$519K |
|
7012
Wintrust Financial
WTFC
$10.8B
| $559K | ﹤0.01% |
7,385
-3,533
| -32% | -$276K |
|
|
SRNE
7013
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $559K | ﹤0.01% |
57,752
-154,849
| -73% | -$1.23M |
|
|
FOLD
7014
CALL
DELISTED
Amicus Therapeutics
FOLD
| $558K | ﹤0.01% |
57,900
-117,100
| -67% | -$1.14M |
|
7015
CALL
Viasat
VSAT
$11.7B
| $558K | ﹤0.01% |
11,200
-32,000
| -74% | -$1.59M |
|
7016
National Vision
EYE
$1.79B
| $557K | ﹤0.01% |
10,888
-23,920
| -69% | -$1.17M |
|
|
HNGR
7017
DELISTED
Hanger Inc.
HNGR
| $557K | ﹤0.01% |
+22,033
| New | +$549K |
|
7018
NETSCOUT
NTCT
$2.81B
| $556K | ﹤0.01% |
19,465
+6,901
| +55% | +$196K |
|
|
RSX
7019
CALL
DELISTED
VanEck Russia ETF
RSX
| $556K | ﹤0.01% |
19,200
+7,000
| +57% | +$192K |
|
|
BORR
7020
Borr Drilling
BORR
$1.29B
| $555K | ﹤0.01% |
335,669
-81,692
| -20% | -$154K |
|
7021
Franklin FTSE Australia ETF
FLAU
$182M
| $555K | ﹤0.01% |
18,173
-28,626
| -61% | -$886K |
|
7022
Advantage Solutions
ADV
$392M
| $554K | ﹤0.01% |
2,053
-5,009
| -71% | -$1.55M |
|
7023
CALL
Hain Celestial
HAIN
$53M
| $554K | ﹤0.01% |
13,800
-3,900
| -22% | -$161K |
|
|
SURF
7024
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $554K | ﹤0.01% |
74,217
-7,696
| -9% | -$59.3K |
|
7025
Standard BioTools
LAB
$307M
| $553K | ﹤0.01% |
89,695
+32,372
| +56% | +$173K |
|
Similar funds
Jane Street's Q2 2021 Portfolio in Review
As of Q2 2021, Jane Street held 10,953 positions worth $256B, up 27% from $201B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Jane Street deployed $36.7B of net new capital in Q2 2021, opening 1,924 new positions and adding to 4,219 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.5% of assets, down from 2.8% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Baidu, an estimated $964M trimmed.
- Jane Street's largest Q2 2021 buy was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.
- Jane Street added most to iShares MBS ETF in Q2 2021, an estimated $629M increase.
- Jane Street's biggest Q2 2021 reduction was Baidu, cutting an estimated $964M.
- Jane Street fully exited Invesco Senior Loan ETF in Q2 2021, selling an estimated $369M.
- Jane Street's ten largest holdings make up 37% of its $256B portfolio in Q2 2021.
- Jane Street opened 1,924 new positions and closed 1,267 in Q2 2021.
- Jane Street's portfolio value rose 27% quarter-over-quarter to $256B.
Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.